The tumor presents a genetic translocation between genes 11 and 22 (t;11:22) that gives rise to a fusion gene (Ewing sarcoma/Friend leukemia integration 1 transcription factor [EWS/FLI1]) with potent oncogenic action. Here, FLI1 is linked to neoplasm.